Science & Technology

STX-005: A Next-Generation Therapy for Autoimmune Disease to Sustain Force Readiness

Department of Defense — Air Force

Opportunity #: FA8649-25-P-0501

Award Ceiling

$1.2M

Award Floor

$1.2M

Close Date

May 31, 2027

442 days left

Total Funding

$1.2M

Expected Awards

Posted Date

Aug 27, 2025

Cost Sharing Required

Grants.gov ID

sbir-FA8649-25-P-0501

Description

SBIR Phase Phase II award: "STX-005: A Next-Generation Therapy for Autoimmune Disease to Sustain Force Readiness" awarded to STRAND THERAPEUTICS INC. in BOSTON, Massachusetts. Funded by Department of Defense (Air Force). Award amount: $1,249,609. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.